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Abstract: The initial discovery of killer toxin-secreting brewery strains of Saccharomyces cerevisiae
(S. cerevisiae) in the mid-sixties of the last century marked the beginning of intensive research in the
yeast virology field. So far, four different S. cerevisiae killer toxins (K28, K1, K2, and Klus), encoded
by cytoplasmic inherited double-stranded RNA viruses (dsRNA) of the Totiviridae family, have been
identified. Among these, K28 represents the unique example of a yeast viral killer toxin that enters
a sensitive cell by receptor-mediated endocytosis to reach its intracellular target(s). This review
summarizes and discusses the most recent advances and current knowledge on yeast killer toxin
K28, with special emphasis on its endocytosis and intracellular trafficking, pointing towards future
directions and open questions in this still timely and fascinating field of killer yeast research.
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1. Introduction
A killer phenotype in yeast was originally discovered in certain strains of the wine and brewery
yeast, Saccharomyces cerevisiae (S. cerevisiae), and was first described in 1963 [1]. Characteristic of all
“killer” yeasts is the production and secretion of a certain type of protein toxin (killer toxin) that is
lethal to sensitive strains of the same or related yeast genera. Soon after the initial studies on the
killer phenomenon in S. cerevisiae, it became evident that an infection with cytoplasmic inherited
double-stranded (ds)RNA viruses is responsible for killer phenotype expression [2]. Interestingly,
the occurrence of dsRNA viruses is not restricted to strains of S. cerevisiae, but rather, is widely
distributed among various yeast species, including Zygosaccharomyces bailii, Hanseniaspora uvarum
and Ustilago maydis [3,4]. Besides non-infectious yeast dsRNA viruses (also designated as virus-like
particles, VLPs), the killer phenotype can also be chromosomally encoded (Williopsis californica) [5] or
associated with linear dsDNA plasmids (Klyveromyces lactis and Pichia acaciae) [6]. The existence of
dsRNA viruses in S. cerevisiae seems to be linked to the absence of RNA interference (RNAi), explaining
why killer systems have so far only been found in RNAi-deficient yeast species, while RNAi-proficient
yeasts did not develop killer strains during evolution [7]. While relatively little is known about the
ecological relevance of killer toxin-producing yeasts, it has been proposed that yeast strains carrying
killer viruses presumably possess a competitive advantage in the natural yeast habitat, in the battle for
resources, by eliminating sensitive yeasts [8].
Based on the killing properties and the lack of cross-immunity, four different dsRNA-encoded
killer types, namely K1, K2, K28, and Klus, have so far been identified in S. cerevisiae [9–12]. Each killer
type shows killing activity against non-killer strains as well as killer strains of different killer types,
while it is protected and immune against its own toxin. In nature, infected yeast cells only harbor a
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single copy of an M-dsRNA genome, whereby the coexistence of multiple M genomes with different
killer specificities is excluded at the replicative level. Artificially, this limitation can be overcome
by introducing cDNAs encoding killer toxins, K2 and K28, into a K1 strain, thereby artificially
generating a triple killer strain that simultaneously expresses all three killer toxins and shows multiple
toxin immunity [13]. To stably maintain a virally-encoded killer phenotype in yeast, two dsRNA
genomes must be present in the cytoplasm of the infected host: an unsegmented 4.6 kb large L-dsRNA
genome of the helper virus ScV-L-A and one of four smaller toxin-encoding M-dsRNA satellite viruses
(ScV-M1, ScV-M2, ScV-M28, or ScV-Mlus) [10,14]. This review will mainly focus on ScV-M28 and its
encoded killer toxin, K28.
2. K28 Phenotype: Origin, Genomic Organization and Viral Replication
The first detailed analysis of the fundamental properties of the K28 killer phenotype in yeast
was published in 1990 [11]. The phenotype was initially found in the S. cerevisiae wine strain 28,
which gave the killer toxin its designation. As already shown for other killer toxins of S. cerevisiae,
K28-producing killer strains harbor two different cytoplasmic persisting dsRNA genomes, which are
separately encapsidated into virus-like particles (VLPs) [15]. The smaller 1.8 kb M-dsRNA genome of
the ScV-M28 satellite/killer virus encodes the unprocessed K28 toxin precursor. The coding (+) strand
of ScV-M28 contains a single open reading frame (ORF) that contains the genetic information for the
unprocessed K28 precursor (also called preprotoxin, pptox) which likewise confers toxin immunity [14].
As classical satellite, ScV-M28 depends on a second virus (ScV-L-A) which functions as a helper virus
required for stable maintenance and replication [16]. The linear L-A genome (4.6 kb) possesses two
ORFs on its positive strand. The major 76 kDa capsid protein, Gag, is encoded by ORF1 and is
required for proper dsRNA encapsidation and VLP formation. ORF2 encodes Pol, an RNA-dependent
RNA-polymerase (RDRP) which is translated as a 180 kDa Gag-Pol fusion protein by a -1 ribosomal
frameshift event [17–19]. Figure 1 summarizes the genomic organization and the coding capacity of
the positive strands of ScV-M28 and ScV-L-A.
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For stable L-A helper and ScV-M28 satellite virus propagation within a killer cell, a subset of at 
least 28 nuclear MAK genes (MAK1, MAK3-MAK27, PET18 as well as SPE2) is required in S. cerevisiae 
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Figure 1. Genomic organisation of the L-A (+) and M28 (+) strands. The initial GAAAAA sequence at
the 5′-end of the M28 (+) ssRNA represents a terminal recognition element (TRE) which is necessary for
the initiation of transcription. M28 (+) ssRNA further contains the toxin-encoding K28 open reading
frame (ORF), a poly(A)-rich region and potential 3′ elements which are required for in vivo RNA
replication (IRE, internal replication enhancer; TRE, 3′ terminal recognition element) and packaging
(VBS, viral binding side). Besides the two ORFs on L-A (+) ssRNA, the position of the −1 frameshift
region, the ncapsidation signal and the replication side for (−) strand synthesis are indicated in
brackets. Reproduced and modified from [10,20], 2011 and 2013, American Society for Cell biology.
For stable L-A helper and ScV-M28 satellite virus propagation within a killer cell, a subset
of at least 28 nuclear MAK genes (MAK1, MAK3-MAK27, PET18 as well as SPE2) is required in
S. cerevisiae [3,21,22]. Mutations in any of these genes results in a rapid loss of M-dsRNA killer viruses,
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while an additional loss of L-A viruses is only observable in ∆mak3, ∆mak10 and ∆pet18 mutants [4].
Although the exact function and interplay of these genes in virus replication and maintenance is not
fully understood, the concentration of free 60S ribosomal subunits seems crucial for efficient yeast
virus propagation [23]. In contrast, recessive mutations in at least six chromosomal “super-killer”
genes (SKI) lead to increased M-dsRNA copy numbers, associated with significantly enhanced killer
toxin biogenesis and secretion [24,25]. For example, ∆ski2 mutants secrete ten times more K28 toxin
than wild-type killers [15]. Experimental results have indicated that SKI genes presumably possess a
negative regulatory function for M-dsRNA virus replication and killer toxin expression [26–28].
During VLP formation, a 39 nm icosahedral capsid, consisting of 60 Gag dimers and one or
two Gag-Pol molecules, is assembled in the yeast cytoplasm [29–32]. So far, no extracellular route
of infection has been described for dsRNA viruses in S. cerevisiae, as the non-infectious virions
typically spread horizontally by heterokaryon formation or cell-to-cell mating [14]. As illustrated in
Figure 2, the replication cycle of an L-A helper virus starts inside each virion with the generation of a
single-stranded L-A plus strand ((+) ssRNA). After export into the yeast cell cytoplasm, (+) ssRNA
transcripts are either translated into the viral proteins, Gag and Gag-Pol, or encapsidated into new
virions [33]. Once the virus assembly is complete, the mature dsRNA genome is generated via
Pol-mediated synthesis of the corresponding L-A minus strand [22,27,34–36]. The formation of
toxin-coding M viruses occurs via the same steps as the L-A replication cycle, with the exception that
two copies of the smaller M-dsRNA genome can be present in a single M virion. This phenomenon has
been designated as “headful packaging”, which is likewise found in some DNA bacteriophages [37,38].
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Figure 2. Replication cycle of L-A helper and M28 killer viruses in S. cerevisiae. The L-A replication
cycle starts in vivo, with the transcription of L-A dsRNA into (+) strands, via he transcriptase
activity of the Gag-Pol fusion protein. After extrusion into the cytoplasm, the majority of L-A (+)
strands are translated into the capsid protein, Gag (grey dot), while only 1–2% are converted into a
Gag-Pol fusion protein (green-grey dot) by a −1 ribosomal frameshift event. Viral L-A (+) strands
further interact with Gag-Pol, which triggers L-A particle assembly and encapsidation [39]. The protein
composition of newly assembled ScV-L-A part cles, eac of them co taining just a single L-A (+) strand,
is identical to that of mature viri ns. In the final step, an L- (−) strand is synthesized by the replicase
activity of Pol, leading to a complete dsRNA genome within each virion. Replication of ScV-M is
analogous to that of ScV-L-A. After in vivo M (+) strand synthesis and subsequent extrusion into the
cytoplasm, M (+) strands are either translated into the unprocessed K28 toxin precursor or bound by
Gag-Pol for subsequent encapsidation into virus particles. ScV-M replication finally finishes with the
synthesis of an M (−) strand. Compared to L-A virions, two M-dsRNA copies can be present in a single
M virion at the same time, due to their smaller genome size.
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3. Viral Preprotoxin Processing and Toxin Secretion
In M28 virus-infected yeast cells, the cytoplasmic M (+) strand is translated into the unprocessed
K28 toxin precursor (pptox) which is post-translationally imported, via Sec61p, into the yeast secretory
pathway, where it undergoes extensive processing steps during toxin maturation and secretion [14,40].
A summary of the multiple enzymatic pptox processing steps in the ER and Golgi is shown in Figure 3.
Figure 3. Schematic K28 preprotoxin (pptox) structure and processing in the secretory pathway.
(a) pptox is completely translated by cytosolic ribosomes and thereafter post-translationally imported
into the ER lumen via complex protein import machinery, including Sec61p, Sec71p, Sec72p Sec62p,
Ssa1p and Ssa2p [40]; (b) Within the ER, the N-terminal signal peptide (pre-sequence) is removed by
signal peptidase (SP) cleavage, the γ-subunit is N-glycosylated (
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Interestingly, major aspects of the enzymatic K28 pptox processing mirror pro-hormone
conversion in mammalian cells [16,43]. As a naturally secreted protein, the unprocessed K28 precursor
contains an N-terminal signal peptide for efficient pptox import into the ER lumen, followed by a
pro-region (also designated δ-subunit) and the two toxin subunits α (10.5 kDa) and β (11.0 kDa) of
mature K28 [14,16,40,44]. While the α-subunit represents the cytotoxic and cell killing polypeptide,
the β-subunit mediates efficient K28 cell surface binding and toxin internalization. During pptox
maturation in the secretory pathway, both toxin subunits are initially separated by an N-glycosylated
γ-sequence which is believed to promote proper precursor folding and disulfide bond formation [45].
The four C-terminal amino acids (HDEL) in the fully processed β-subunit represent a classical ER
retention motif [44,46], which is initially masked by a terminal arginine residue to allow efficient toxin
transport through the secretory pathway and to prevent H/KDEL receptor-mediated toxin retrieval
from the Golgi and retrograde transport to the ER [14]. As summarized in Figure 3, the toxin precursor
is finally processed into a biologically active α/β heterodimer, whose subunits are covalently linked by
a single disulfide bond [16,44]. In contrast to the former assumption that the cysteine residue, Cys340,
in β is part of the inter-chain disulfide that joins both subunits in the mature K28 toxin [44], it was
recently shown that the inter-chain disulfide is formed between the single cysteine in α (Cys56) and
Cys333 in β. Within the cytotoxic α/β heterodimer, Suzuki et al. have postulated that the β-subunit
contains a single free cysteine and an additional intra-chain disulfide between two of the remaining
cysteines in β (C292, C307 and C340) [42].
4. Cell Wall Binding and Endocytosis of K28
Bacterial A/B toxins, such as cholera toxin or Shiga toxin, initially bind to specific receptors at
the mammalian cell surface to subsequently enter cells by endocytosis and reach their final target in
the cytosol [47]. In the case of K28, early studies in the nineties have demonstrated that a specific
primary receptor in the yeast cell wall allows rapid K28 absorption via an energy-independent binding
mechanism (Figure 4). Later on, α-1,3- and/or α-1,2-mannotriose side-chains of a 185 kDa cell wall
mannoprotein were identified as primary K28 receptor and cell wall binding sites [48–51]. In line with
this, mutations in chromosomal yeast genes encoding mannosyltransferases, including Mnn1p and
Mnn5p, which catalyze mannoprotein side-chain synthesis and structure, prevent toxin binding and,
consequently, result in K28-resistance [49]. However, besides alterations in cell wall mannoproteins,
a large number of additional deletion mutants affecting protein mannosylation, lipid biogenesis and
GPI anchor biosynthesis have likewise been shown to negatively affect K28 cell surface binding.
Accordingly, the primary process of toxin binding to sensitive target cells seems much more complex
than originally thought, depending on a variety of factors which ensure optimal cell surface binding of
the K28 toxin [52].
In contrast to the ionophoric killer toxins, K1 and K2 [53–55], K28 is taken up via receptor-mediated
endocytosis. Consequently, yeast deletion mutants, such as ∆end3 and ∆end4, with severe defects in
early steps of both fluid-phase and receptor-mediated endocytosis, become toxin resistant, due to a
block in K28 uptake from the cell surface [56]. Since yeast cell spheroplasts, lacking an intact cell wall
and primary toxin receptors, are still phenotypically K28 sensitive, the existence of a secondary toxin
receptor at the level of the yeast plasma membrane (PM) was proposed for a long time, but only recently
identified. In this respect, it was demonstrated that a minor fraction of PM-localized Erd2p, the yeast
H/KDEL receptor, is responsible for K28 plasma membrane binding and internalization (Figure 4).
Thereby, Erd2p interacts with the C-terminal HDEL motif of the β-subunit, thereby triggering toxin
uptake by receptor-mediated endocytosis. The current model of host cell intoxication by K28 is
supported by two major observations: (i) a K28 variant, lacking a C-terminal HDEL motif in β is
not taken up by sensitive yeast cells and (ii) yeast cells lacking Erd2p are unable to internalize cell
bound killer toxins [57]. Although it is not yet clear how the resulting Erd2p/K28 receptor/toxin
complex is recognized by the endocytosis machinery and how its internalization is regulated, it is
important to note that efficient K28 uptake not only requires a correct protein/lipid environment
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in the plasma membrane, but also a functional AP2 complex. Mutations in individual subunits
of the yeast AP2 complex completely block K28 internalization and thus, prevent toxin-mediated
cell killing. In this context, the AP2 complex most likely acts as a specific adaptor to connect the
receptor/toxin complex with the clathrin coat of the endocytosis machinery [52]. Interestingly, receptor
(mono)ubiquitylation, via Ubc4p (E2) and Rsp5p (E3), seems likewise required for efficient K28
endocytosis, since a chromosomal deletion of UBC4 and/or temperature-sensitive mutations in RSP5,
significantly reduce the amount of internalized toxin [58]. However, further experiments are needed to
identify the underlying mechanisms that regulate K28 endocytosis.
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Figure 4. Sch matic outline of K28 cell surface i ing and intern lization. Initially, the β-subunit
of the mature K28 toxin rapidly binds in an energy ependent process to primary mannoprotein
receptors in the yeast cell wall. In a second energy-dependent step, K28 penetrates the cell wall and
subsequently interacts with the plasma membrane (PM)-localized pool of the yeast H/KDEL receptor
Erd2p [14]. This interaction is mediated by the C-terminal HDEL motif of the toxin’s β-subunit, which
finally triggers receptor/toxin complex internalization by clathrin-mediated endocytosis.
5. Intracellular K28 Trafficking from the Plasma Membrane to the ER
In the current model, K28/Erd2p complexes are internalized and targeted to an early endosomal
compartment, from where the receptor/cargo complex travels the secretion pathway in reverse and
finally exits the ER lumen to enter the yeast cytoplasm. Due to pH-dependent binding of the toxin’s
ER retention/targeting motif (HDEL) and Erd2p [59], it is conceivable that K28 initially binds to
PM-localized Erd2p receptors in the mildly acidic milieu (pH ~4.7) of the extracellular environment.
The complex remains associated during endocytosis and retrograde transport, through the likewise
mildly acidic environment of the endosomal and Golgi compartments (pH ~6.0–6.2) until it reaches the
pH neutral (pH ~7.2) ER lumen (Figure 5). So far, it is not precisely known how the endosome-to-Golgi
transport of the receptor/toxin complex is regulated and how its vacuolar transport and degradation
is largely prev n ed. The hypersensitive K28 phenotype of y ast mutant defective in vacuolar HOPS
tethering complex c mponents, however, indicates that a certain fraction of the toxin/receptor complex
is indeed targeted to the vacuole and degraded [52]. It therefore can be assumed that defects in the
vacuolar degradation pathway result in increased toxin traffic to the ER, a phenomenon which has
also been described for bacterial and plant A/B toxins, such as Shiga-like toxins and ricin [60].
Over the years, several studies identified a number of yeast genes whose gene products are
required for proper anterograde and retrograde transport of cellular proteins and likewise are
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important for K28 trafficking [52,56,58]. Unfortunately, phenotypic analysis of yeast mutants defective
in the corresponding transport genes is not trivial, since different possibilities exist to explain how
these mutations could affect toxin transport. Defects in general protein transport can affect protein
traffic, within and through the secretory pathway, eventually leading to an altered amount of protein
transport to the plasma membrane, which could lead to a decrease in the Erd2p copy number at the
cell surface and/or indirectly affect retrograde K28 transport. On the other hand, direct effects on
retrograde toxin transport could also lower the total number of toxin molecules that reach the ER
and/or cytosol. It will be a challenging future task to clarify in which ways such mutations affecting
K28 transport through the endomembrane system.
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Figure 5. Schematic overview of retrograde toxin trafficking routes in a K28 sensitive target cell.
(a) Biologically active K28 toxin (α-subunit shown in orange, β-subunit in green) initially binds
to primary receptors in the yeast cell wall and then interacts with a secondary receptor, the yeast
H/KDEL receptor, Erd2p, at the level of the plasma membrane; (b) After clathrin-mediated endocytosis,
a minor fraction of internalized toxin/rece tor complexes is targeted to th v cuole and degraded
(c), while toxin/receptor complexes that escaped degradation are transported in a retrograde manner
to the pH-neutral ER lumen, where the receptor/cargo complexes dissociate and release K28
(d + e). The natural pH gradient between the extracellular killer yeast environment (pH 4.7) and
the intracellular compartment of the ER (pH 7.2) presumably prevents premature toxin dissociation
from its receptor (Erd2p) and likewise prevents spontaneous formation of inactive K28 oligomers
(see also Chapter 7 below); (f) In contrast to for example, cholera toxin, ER exit of K28 occurs in its
oxidized a d α/β heterodimeric conformation and is likely gated by the major protein import/export
channel in the ER membrane, Sec61p [56,58]; (g) Within the cytosol, the heterodimeric toxin dissociates
into its subunits: while the β-subunit is ubiquitylated and proteasomally degraded; (h) the α-subunit
enters the nucleus and finally kills, by causing an irreversible G1/S cell cycle arrest and inhibiting
DNA synthesis.
6. ER-To-Cytosol Retrotranslocation
Once the K28 toxin reaches the ER-lumen, it has to undergo conformational changes to allow
its export into the cytosol. Interestingly, and in contrast to many other A/B toxins, the subunit
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connecting disulfide in the α/β toxin remains intact during retrotranslocation and gets reduced in the
cytosol. Heiligenstein et al. further demonstrated that certain chaperones in the ER lumen, including
Kar2p, protein-disulfide isomerase (Pdi1p), the Hsp40 chaperones Jem1p and Scj1p, as well as a
proper maintenance of Ca2+ homeostasis in the ER, are important factors for K28 export into the
cytosol. In contrast, neither ubiquitylation nor ER-associated degradation (ERAD) machinery are
required for efficient K28 retrotranslocation [58]. This mechanism contrasts K28 from other A/B toxins
(e.g., cholera toxin or ricin) that have been shown to parasitize components of the ERAD machinery
to exit the ER after disulfide bond reduction [58,61–64]. For these toxins, it has been assumed that
the release of the corresponding cytotoxic subunit, before and/or during ER-to-cytosol transport,
functions as an initiation signal for toxin retrotranslocation from the ER. Most recently, a model of
K28 host cell intoxication was postulated, in which the intracellular pH gradient from the PM to the
ER lumen (ranging from mildly acidic to neutral pH conditions, Figure 5) activates and rearranges
the thiols in the α/β heterodimer [42]. In the case of K28, this pH-triggered rearrangement leads to
the formation of inactive toxin trimers, tetramers and oligomers in vitro. Interestingly, this oligomer
formation seems prevented in vivo by the activity of the ER chaperon, Pdi1p, keeping K28 in its
heterodimeric conformation [42]. It has been speculated that Pdi1p induces some additional, and so
far unknown, structural changes in K28, which ensure toxin retrotranslocation into the cytosol on the
oxidized K28 heterodimer [58]. In the absence of Pdi1p, the activated and rearranged thiols would
generate the driving force for premature release of the cytotoxic α-subunit from the heterodimer [42].
This novel mechanism represents a unique A/B toxin strategy to penetrate and finally kill a target cell.
Nevertheless, further efforts are needed to identify the specific structural changes in K28 which ensure
efficient toxin export into the cytosol; Figure 6 illustrates a simplified current model of K28 structural
rearrangements, during intracellular transport.
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Figure 6. Model of pH-driven and Pdi1p-dependent thiol rearrangements in the K28 heterodimer
during its retrograde transport to the cytosol. In he natural habitat nd extracellular nv ronment of a
K28 killer yeast, the mildly acidic pH of 4.7 stabilizes the biologically active K28 toxin and keeps it in a
heterodimeric conformation. During host cell intoxication, the α/β heterodimer faces a continuous
increase in intra-compartmental pH. The neutral pH leads to fast deprotonation of free sulfhydryls in
the β-subunit and subsequently causes the formation of inactive K28 trimers, tetramers and oligomers.
Due to the presence of the chaperone, Pdi1p, in the ER-lumen, these disulfide bond rearrangements are
efficiently prevented, in vivo and in vitro, ensuring ER exit of the heterodimeric toxin. At the neutral
pH of the yeast cell cytosol, the intra-chain disulfide is cleaved through nucleophilic attack of a reactive
thiol in β, which finally releases the monomeric α-subunit. This model is reproduced and modified
from [42], 2017, American Society for Cell biology.
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7. Mode of K28 Toxicity
In the natural yeast habitat of limiting nutrients, K28 killer strains secrete mature K28 toxin into
the extracellular environment to outcompete sensitive yeasts. After receptor-mediated toxin uptake via
Erd2p and retrograde transport through the secretory pathway into the cytosol of a sensitive yeast cell,
the cytotoxic α-subunit is released from the heterodimer and enters the nucleus by passive diffusion,
due to its low molecular weight of 10.5 kDa. In this respect, in vivo toxicity of the α-subunit can be
significantly enhanced by the addition of a C-terminal nuclear localization sequence (NLS) [14], while it
is artificially reduced in an α-variant containing a nuclear export sequence (NES) (unpublished data).
However, the underlying mechanisms of how K28-α efficiently enters the nucleus and finally kills are
still largely unknown. Nuclear proteins, which have already been identified as interaction partners
of K28, belong to cellular proteins that are centrally involved in cell cycle control, gene expression
and chromatin remodeling. In addition, it has been shown that mutations in yeast genes encoding
subunits of the mediator complex, RNA polymerase II, and/or components of the SIR-, SWR1 and
ASTRA complexes, all dramatically reduce K28 sensitivity in their corresponding genetic background,
however, their specific roles and interplays are still unknown [52].
With respect to the mode of K28-induced cell killing, two different dose-dependent phenotypes
have been identified: low killer toxin concentrations (<1 pM) induce an apoptotic cell death response
in toxin-treated cells, with typical markers, such as DNA fragmentation, chromatin condensation, and
phosphatidylserine exposure, at the outer plasma membrane [65]. Furthermore, apoptotic cell killing
by K28 was shown to depend on the presence of yeast caspase (Yca1p) and the generation of reactive
oxygen species (ROS) [66]. This scenario of cell killing closely reflects the natural situation of low
K28 concentrations in a yeast habitat and, thus, toxin-induced apoptosis seems a crucial, if not major
mechanism by which K28-secreting killer strains outcompete and kill sensitive yeasts. In contrast,
under laboratory conditions of high toxin concentrations (≥10 pM), cell killing occurs through necrosis,
during which cells arrest at the G1/S boundary of the cell cycle with a medium-size bud and a single
nucleus in the mother cell with pre-replicated (1n) DNA [67]. Furthermore, inhibition of DNA synthesis
was also observed under high toxin concentrations [48,65]. Interestingly, another yeast killer toxin
(PMKT2) from Pichia membranifaciens shows nearly the same killing phenotype after application of high
and low toxin doses, while both the intoxication mechanism(s) and cellular target(s) of PMKT2 are
completely different from K28 [68]. Hence, apoptosis is not only triggered during the pathogenesis of
various virus infections in mammals, it is likewise activated by different yeast killer toxins, to eliminate
target cells [69]. In sum, the killer toxin K28 has developed an elegant, simple and unique strategy to
intoxicate and kill sensitive cells by targeting evolutionary highly-conserved proteins with essential cell
functions. Moreover, this strategy largely avoids the occurrence of spontaneous mutations resulting in
toxin resistance, as most gene products that are parasitized by K28 are genetically encoded by essential
yeast genes.
8. Toxin Immunity
As toxin cell binding, uptake and retrograde transport in a K28-secreting killer cell occurs in exactly
the same way as in a sensitive target cell, K28 killer cells must be protected against their own toxins.
This represents a major difference to A/B toxin-producing bacteria, such as Vibrio cholerae (cholera toxin)
or Shigella dysenteriae (Shiga toxin), which secrete protein toxins that selectively kill eukaryotic
cells, making a protecting immunity mechanism dispensable for a prokaryotic toxin-producing
microorganism [47]. In K28 killer strains, functional immunity is manifested by an intrinsic mechanism,
which allows rapid degradation of the internalized α/β toxin after retrotranslocation into the host
cytosol (Figure 7).
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Figure 7. Model of the protecting toxin immunity mechanism in a K28 killer yeast. After toxin
internalization and retrotranslocation of mature K28 from the ER into the cytosol, a cytosolic immunity
complex is formed between the re-internalized α/β toxin and the unprocessed toxin precursor (pptox)
which is encoded by the M28 killer virus and post-translationally imported into the ER lumen. Within
each K28/pptox complex, the β-subunit of pptox and mature α/β toxin is poly-ubiquitylated (•)
and degraded by the proteasome, thereby protecting a K28 killer cell against the lethal action of K28.
In addition, free cytosolic and non-ubiquitylated pptox can enter the secretory pathway for enzymatic
processing and toxin maturation, resulting in the secretion of biologically active K28.
Once K28 reaches the cytosol, it forms a complex with the fully translated pptox precursor that
has not yet been post-translationally imported into the ER [14]. Thus, K28 immunity is severely
impaired when the natural N-terminal pre-sequence of K28 is replaced by the co-translationally active
signal peptide from K1 pptox [40]. Within the immunity complex, the β-subunit(s) of mature K28 and
K28 pptox are selectively poly-ubiquitylated and immediately targeted for proteasomal degradation.
Changes in cellular ubiquitin homeostasis, e.g., induced by overexpressing mutant ubiquitin or by
blocking deubiquitylation, severely impair functional toxin immunity and result in a suicidal K28
phenotype [40]. Due to an excess of non-complexed K28 precursor molecules in the killer strain cytosol,
a pptox fraction is likewise imported into the ER lumen, subsequently processed and finally secreted
as an α/β heterodimeric and biologically active toxin. This elegant strategy guarantees that K28 killer
strains are efficiently protected against their own toxins and, consequently, provides an evolutionary
growth advantage over sensitive yeast strains. Since the molecular mechanism of toxin immunity has
so far only been identified for K28, it is still a mystery how toxin immunity is realized in other killer
toxin secreting yeasts.
9. Open Questions and Future Perspectives
In the last decades, intensive research in the field of virus-infected killer yeasts has discovered
the fundamental principles underlying killer phenotype expression, maintenance and transmission to
progeny cells. The knowledge of K28 precursor processing has further helped to understand the basic
mechanisms of A/B toxin and pro-hormone conversion in higher eukaryotes [14]. Moreover, recent
data has generated a more detailed picture of toxin internalization and intracellular trafficking
from the plasma membrane to the host cell cytosol [52,57]. The finding that pH-triggered disulfide
rearrangements in the yeast killer toxin, K28, are crucial for host cell killing, represents a further
piece in the puzzle to uncover the complete intoxication mechanism of this unique killer toxin [42].
However, some parts of the K28 intoxication process, including the precise mode of cell killing, are still
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poorly understood or simply unknown. Although the dose-dependent effects of K28-treated cells are
well described (G1/S cell cycle arrest at high K28 concentration, apoptosis at low toxin concentration),
the underlying mechanisms and cellular targets required for K28-mediated cell killing are still largely
unknown. In future studies, it therefore will be a great benefit to successfully implement new methods
and techniques, such as biochemical cross-linking and APEX proximity labelling, to identify the cellular
target(s) of K28.
Another important issue in future yeast killer toxin research will be to resolve the
three-dimensional structure of the toxins. Up to now, regrettably, no such information has been
available for any of the S. cerevisiae killer toxins, in the literature. Furthermore, an in silico analysis
did not show any homology to other known proteins in current databases. Another critical issue
that K28 research needs to address is the isolation and purification of high yields of biological active
toxin which would be needed for crystallization and X-ray analysis or NMR spectroscopy. Commonly
used affinity purification methods are usually performed at higher pH (pH > 6), which irreversibly
inactivates K28 during the purification process (unpublished data). Using the methylotrophic yeast,
Pichia pastoris, which was demonstrated to be a suitable host for the successful expression and secretion
of the cytotoxic K28 toxin [70], might be a fruitful strategy for high-level K28 production.
Our current knowledge of killer toxin cell binding and intracellular trafficking mainly arises
from genetic screens for yeast mutants with altered K28 sensitivity. To overcome this methodical
limitation, the construction of fluorescent and biologically active K28 variants is essential to monitor
in vivo intoxication in real time, through live cell imaging and high-resolution microscopy. Until now,
these attempts have mainly failed, due to the toxin’s sensitivity to pH changes and/or epitope
extensions of the cytotoxic α-subunit, which has always led to the production of non-toxic K28 variants
(unpublished data).
In addition to the aforementioned aspects, the following new questions have arisen from more
recent studies on the yeast K28 toxin: What are the exact structural changes mediated by Pdi1p
during ER-to-cytosol retrotranslocation of the heterodimeric toxin? How does K28α enter the nucleus
and which components are required for retrograde toxin trafficking from endosomes through the
Golgi to the ER. Besides its general importance in deepening the overall understanding of basic
processes in eukaryotic cell biology, the K28 toxin has the potential to be used in various fields of
applied biotechnology and biomedicine. In this context, for instance, triple K1/K2/K28 killer yeast
strains have been constructed that might be useful as biocontrol agents and starter cultures in wine
and beer fermentation, to prevent or eliminate contamination with undesired yeasts, like Candida or
Pichia [4,13,71]. Furthermore, and directly related to the most recent findings on K28 in intoxication
and intracellular transport, it might be conceivable for future studies to use the β-subunit of K28
as specific transport vehicle for the targeted import of recombinant proteins or polypeptide-based
therapeutics into a eukaryotic target cell, thereby ensuring more efficient transport of chimeric
K28β/protein fusions from the plasma membrane to the cytosol and to largely prevent or minimize
vacuolar/lysosomal degradation.
10. Conclusions
Many new aspects of fundamental cellular processes have been learned over the past decades
by studying virus-infected killer yeasts and analyzing intracellular toxin transport, maturation and
secretion. In the case of K28, a wide range of important cellular processes, including receptor-mediated
endocytosis, retrograde protein transport, ER-to-cytosol retrotranslocation, proteasomal degradation,
and even apoptotic host-cell responses have been investigated in more detail. Future studies will
greatly benefit from the continuous and fast development of high resolution imaging techniques and
novel biochemical tools that can help to fully uncover the K28 intoxication mechanism and answer
open questions in this still timely and fascinating research field.
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